Cargando…

Spontaneous arising of a lymphoblastoid B‐cell line harbouring a pre‐leukemic DNMT3A mutation in acute myeloid leukaemia cell culture

Detalles Bibliográficos
Autores principales:	Hayun, Michal, Szwarcwort, Moran, Rosenberg, Dina, Sahar, Dvora, Ofran, Yishai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581312/ https://www.ncbi.nlm.nih.gov/pubmed/34651440 http://dx.doi.org/10.1111/jcmm.16992

Ejemplares similares

ERK Activity in Immature Leukemic Cells Drives Clonal Selection during Induction Therapy for Acute Myeloid Leukemia
por: Hayun, Michal, et al.
Publicado: (2020)

Chasing quality remission in acute myeloid leukemia: intensity of induction and residual disease
por: Ofran, Yishai
Publicado: (2023)

Oncogenic Roles and Inhibitors of DNMT1, DNMT3A, and DNMT3B in Acute Myeloid Leukaemia
por: Wong, Kah Keng, et al.
Publicado: (2019)

Genetic Stratification in Myeloid Diseases: From Risk Assessment to Clinical Decision Support Tool
por: Ofran, Yishai
Publicado: (2014)

Antagonism of drugs used in leukaemia therapy to the killing of human lymphoblastoid cells by steroid.
por: Gledhill, R. M., et al.
Publicado: (1981)

Proceedings: Cultured lymphoblastoid lines as a model for leukaemia/lymphoma.
por: Steel, C. M.
Publicado: (1975)

Efficacy and Safety Profile of Ivosidenib in the Management of Patients with Acute Myeloid Leukemia (AML): An Update on the Emerging Evidence
por: Stemer, Galia, et al.
Publicado: (2021)

A tale of two siblings: two cases of AML arising from a single pre-leukemic DNMT3A mutant clone
por: Hahn, C N, et al.
Publicado: (2015)

Daratumumab: new indications revolving around "off-targets"
por: Ofran, Yishai
Publicado: (2021)

A chemotherapy-free regimen for Philadelphia chromosome-positive acute lymphoblastic leukemia: are we there yet?
por: Ofran, Yishai
Publicado: (2021)

Epigenetic Guardian: A Review of the DNA Methyltransferase DNMT3A in Acute Myeloid Leukaemia and Clonal Haematopoiesis
por: Chaudry, Sabah F., et al.
Publicado: (2017)

DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
por: Sato, Hanae, et al.
Publicado: (2016)

How I diagnose and manage Philadelphia chromosome-like acute lymphoblastic leukemia
por: Frisch, Avraham, et al.
Publicado: (2019)

DNMT3A mutation leads to leukemic extramedullary infiltration mediated by TWIST1
por: Xu, Jie, et al.
Publicado: (2016)

Leukemic stem cells and therapy resistance in acute myeloid leukemia
por: Stelmach, Patrick, et al.
Publicado: (2023)

Early death in acute promyelocytic leukemia: time to redefine risk groups
por: Salman, Meira Yisraeli, et al.
Publicado: (2022)

Implementation of data protection laws in the European Union and in California is associated with a move of clinical trials to countries with fewer data protections
por: Yom-Tov, Elad, et al.
Publicado: (2022)

Decreased melanoma CSF-1 secretion by Cannabigerol treatment reprograms regulatory myeloid cells and reduces tumor progression
por: Wyrobnik, Iris, et al.
Publicado: (2023)

The landscape of somatic mutations in lymphoblastoid cell lines
por: Caballero, Madison, et al.
Publicado: (2023)

The landscape of somatic mutations in lymphoblastoid cell lines
por: Caballero, Madison, et al.
Publicado: (2023)

The Complexity of Targeting PI3K-Akt-mTOR Signalling in Human Acute Myeloid Leukaemia: The Importance of Leukemic Cell Heterogeneity, Neighbouring Mesenchymal Stem Cells and Immunocompetent Cells
por: Brenner, Annette K., et al.
Publicado: (2016)

Extracellular idiotypic immunoglobulin arising from human leukemic B lymphocytes
Publicado: (1980)

Chemotherapy of the Myeloid Leukaemias
por: Stuart, John
Publicado: (1980)

Hexokinase II inhibition by 3-bromopyruvate sensitizes myeloid leukemic cells K-562 to anti-leukemic drug, daunorubicin
por: Rai, Yogesh, et al.
Publicado: (2019)

Retinoic acid-induced gene expression in normal and leukemic myeloid cells
Publicado: (1986)

Can immunotherapy specifically target acute myeloid leukemic stem cells?
por: Snauwaert, Sylvia, et al.
Publicado: (2013)

Targeting Leukemic Stem Cells in Chronic Myeloid Leukemia: Is It Worth the Effort?
por: Soverini, Simona, et al.
Publicado: (2021)

DNMT3A low-expression is correlated to poor prognosis in childhood B-ALL and confers resistance to daunorubicin on leukemic cells
por: Li, Weijing, et al.
Publicado: (2023)

Strategies For Targeting Chronic Myeloid Leukaemia Stem Cells
por: Carrà, Giovanna, et al.
Publicado: (2019)

Instability at Short Tandem Repeats in Lymphoblastoid Cell Lines
por: Lee, Jae-Eun, et al.
Publicado: (2013)

Limitations of lymphoblastoid cell lines for functional analysis of SNPs
por: Pathak, Hansi, et al.
Publicado: (2017)

Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
por: Ladikou, E. E., et al.
Publicado: (2020)

Correction to: DNMT3A low-expression is correlated to poor prognosis in childhood B-ALL and confers resistance to daunorubicin on leukemic cells
por: Li, Weijing, et al.
Publicado: (2023)

Leukemic stem cell phenotype is associated with mutational profile in acute myeloid leukemia
por: Han, Heejoo, et al.
Publicado: (2021)

Targeting Mitochondrial Oxidative Phosphorylation Eradicates Acute Myeloid Leukemic Stem Cells
por: Peng, Meixi, et al.
Publicado: (2022)

The Yin-Yang of myeloid cells in the leukemic microenvironment: Immunological role and clinical implications
por: Magalhães-Gama, Fábio, et al.
Publicado: (2022)

The role of mitochondrial proteases in leukemic cells and leukemic stem cells
por: Mirali, Sara, et al.
Publicado: (2020)

Erythropoiesis in Murine Myeloid Leukaemia
por: Tanaka, T.
Publicado: (1970)

Desacetylmethylcolchicine in the Treatment of Myeloid Leukaemia
por: Jelliffe, A. M., et al.
Publicado: (1956)

A Case of Myeloid Leukæmia
por: Ghosal, J. N.
Publicado: (1931)

Cannot write session to /tmp/vufind_sessions/sess_2g6a62e0tcuakmh1961uvoup6i